Vaccine development services: COVID19 vaccine projects encouraged to apply

Researchers developing vaccine candidates against COVID19 can benefit from TRANSVAC2 services

The European vaccine infrastructure TRANSVAC2 offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use. Any target disease is eligible, including COVID19! With a few exceptions, services are free of charge.

Next deadline for application: April 15th, 2020

For more info, see file attached and: www.transvac.org